company background image
KIP logo

Kolinpharma BIT:KIP Stock Report

Last Price

€9.90

Market Cap

€15.9m

7D

0%

1Y

22.8%

Updated

01 Nov, 2023

Data

Company Financials +

KIP Stock Overview

Kolinpharma S.p.A. operates as a nutraceuticals company in Italy.

KIP fundamental analysis
Snowflake Score
Valuation0/6
Future Growth1/6
Past Performance2/6
Financial Health6/6
Dividends0/6

Kolinpharma S.p.A. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Kolinpharma
Historical stock prices
Current Share Price€9.90
52 Week High€10.00
52 Week Low€6.98
Beta0.65
11 Month Change0%
3 Month Change-0.50%
1 Year Change22.83%
33 Year Change22.22%
5 Year Change56.47%
Change since IPO41.65%

Recent News & Updates

Kolinpharma (BIT:KIP) Is Looking To Continue Growing Its Returns On Capital

Jun 17
Kolinpharma (BIT:KIP) Is Looking To Continue Growing Its Returns On Capital

What Does Kolinpharma S.p.A.'s (BIT:KIP) Share Price Indicate?

Dec 01
What Does Kolinpharma S.p.A.'s (BIT:KIP) Share Price Indicate?

Recent updates

Kolinpharma (BIT:KIP) Is Looking To Continue Growing Its Returns On Capital

Jun 17
Kolinpharma (BIT:KIP) Is Looking To Continue Growing Its Returns On Capital

What Does Kolinpharma S.p.A.'s (BIT:KIP) Share Price Indicate?

Dec 01
What Does Kolinpharma S.p.A.'s (BIT:KIP) Share Price Indicate?

An Intrinsic Calculation For Kolinpharma S.p.A. (BIT:KIP) Suggests It's 46% Undervalued

Aug 25
An Intrinsic Calculation For Kolinpharma S.p.A. (BIT:KIP) Suggests It's 46% Undervalued

We Think Kolinpharma (BIT:KIP) Can Stay On Top Of Its Debt

Jun 08
We Think Kolinpharma (BIT:KIP) Can Stay On Top Of Its Debt

Do Kolinpharma's (BIT:KIP) Earnings Warrant Your Attention?

May 21
Do Kolinpharma's (BIT:KIP) Earnings Warrant Your Attention?

Is There An Opportunity With Kolinpharma S.p.A.'s (BIT:KIP) 35% Undervaluation?

May 03
Is There An Opportunity With Kolinpharma S.p.A.'s (BIT:KIP) 35% Undervaluation?

Some Shareholders Feeling Restless Over Kolinpharma S.p.A.'s (BIT:KIP) P/E Ratio

Apr 13
Some Shareholders Feeling Restless Over Kolinpharma S.p.A.'s (BIT:KIP) P/E Ratio

What Does Kolinpharma S.p.A.'s (BIT:KIP) Share Price Indicate?

Feb 20
What Does Kolinpharma S.p.A.'s (BIT:KIP) Share Price Indicate?

Is Weakness In Kolinpharma S.p.A. (BIT:KIP) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Dec 28
Is Weakness In Kolinpharma S.p.A. (BIT:KIP) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

These 4 Measures Indicate That Kolinpharma (BIT:KIP) Is Using Debt Reasonably Well

Nov 22
These 4 Measures Indicate That Kolinpharma (BIT:KIP) Is Using Debt Reasonably Well

Shareholder Returns

KIPIT Personal ProductsIT Market
7D0%-2.9%-3.1%
1Y22.8%7.6%17.9%

Return vs Industry: KIP exceeded the Italian Personal Products industry which returned 7.4% over the past year.

Return vs Market: KIP exceeded the Italian Market which returned 17.6% over the past year.

Price Volatility

Is KIP's price volatile compared to industry and market?
KIP volatility
KIP Average Weekly Movement1.1%
Personal Products Industry Average Movement4.5%
Market Average Movement4.1%
10% most volatile stocks in IT Market6.7%
10% least volatile stocks in IT Market2.5%

Stable Share Price: KIP has not had significant price volatility in the past 3 months.

Volatility Over Time: KIP's weekly volatility (1%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2013107Rita Petrelliwww.kolinpharma.com

Kolinpharma S.p.A. operates as a nutraceuticals company in Italy. The company engages in the development and marketing of food supplements. It provides multivitamins, energizers and dietetics, and drugs.

Kolinpharma S.p.A. Fundamentals Summary

How do Kolinpharma's earnings and revenue compare to its market cap?
KIP fundamental statistics
Market cap€15.91m
Earnings (TTM)€342.34k
Revenue (TTM)€15.62m

46.5x

P/E Ratio

1.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
KIP income statement (TTM)
Revenue€15.62m
Cost of Revenue€7.39m
Gross Profit€8.23m
Other Expenses€7.89m
Earnings€342.34k

Last Reported Earnings

Dec 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)0.21
Gross Margin52.71%
Net Profit Margin2.19%
Debt/Equity Ratio105.3%

How did KIP perform over the long term?

See historical performance and comparison